Alimera Sciences, Inc.
The momentum for this stock is not very good. Alimera Sciences, Inc. is not very popular among insiders. Alimera Sciences, Inc. is a mediocre stock to choose.
Log in to see more information.
Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It ope...
News
Alimera Sciences: Deal Closing After All, CVR Still Attractive
SeekingAlpha Alimera Sciences: Deal Closing After All, CVR Still Attractive...\n more…
ANI Pharmaceuticals, Alimera Sciences deal set to close Monday
Seeking Alpha - Healthcare ANI Pharmaceuticals, Alimera Sciences deal set to close Monday...\n more…
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
Business Wire ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (ANI) and Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera or the Company) today jointly announced that they have scheduled the closing of their transaction...\n more…
Alimera Sciences falls after it sues ANI Pharmaceuticals to close deal (update)
SeekingAlpha.com: All News Alimera Sciences files lawsuit against ANI Pharmaceuticals over failed merger, causing stock to plummet 25% in premarket trading.\n more…